Non-inflamed samples had intermediate HK2 expression levels (Fig. 5C), which indicates that HK2 expression is dysregulated in enterocytes of IBD patients also in the absence of an overt inflammation. This evidence concerns the gene HK2 and inflammatory bowel disease.